The Challenges & Demands when Establishing a New Cell Line Development Lab
Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be presenting and exhibiting at SLAS 2020, taking place 25-29 January, San Diego. The event showcases the latest cutting-edge developments in laboratory automation and screening, as well as highlighting recent applications in drug discovery research.
The cell line development (CLD) market is growing rapidly and an increasing number of new cell line development labs continue to be established around the world. The main challenge for many of these groups is how to go about purchasing the right platform solution, especially for scientists who may have limited domain experience. This solution must ensure they can implement CLD workflows quickly and cost-effectively, and successfully deliver on cell line project commitments and future demands.
At SLAS 2020, Ian Taylor, Chief Commercial Officer at Solentim, will share his insights on how to go about making this selection, the factors to be considered and how Solentim is uniquely positioned to help new CLD groups. His spotlight presentation, ‘The Challenge & Demands for Establishing a New Cell Line Development Lab’, will take place on Tuesday 28th, 12:00 PM – 12:20 PM in the Exhibition Theatre.
Mark Truesdale, Chief Marketing Officer, Solentim, commented: “With an increasing focus on automation and cellular imaging in biologics cell line development, this is the ideal conference for us to reconnect with existing customers and meet new and inspiring companies. We are excited to kick off 2020 at what is sure to be a great event”.
Solentim will be at booth #1809 throughout the event – please come and say hi, or get in touch to arrange a meeting.